Approximately 4050% of women who track their cycles during perimenopause experience some form of spotting
Zhang YJ, Gan RY, Li S, Zhou Y, Li AN, Xu DP, et al
The first cohort comprised individuals who started and continued either a GLP-1 receptor agonist or DPP-4 inhibitor for the first time between January 1, 2007, and December 31, 2020
Patients who complete their full peptide cycles and attend scheduled bloodwork reviews report significantly better results than those who miss appointments or modify protocols on their own
A study in the Journal of Applied Physiology found that BPC-157 promoted tendon fibroblast survival and migration, suggesting faster tendon repair (Chang et al., 2011)
At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported on Wednesday in The BMJ